Tuesday's pre-market session: top gainers and losers

NEURONETICS INC (STIM)       6.19   -0.01 (-0.16%)

After market: 6.6 +0.41 (+6.62%)


News Image
Tuesday's pre-market session: top gainers and losers2 months ago - Chartmill

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.

Pre-market gainers

TickerChangeComment
KPRX4.0K%KIORA PHARMACEUTICALS INC's (NASDAQ:KPRX) stock price increased by 4.0K% to $6.55. NASDAQ:KPRX seems to be recovering from a -10.05% loss in the previous session.
IONM28.03%ASSURE HOLDINGS CORP's (NASDAQ:IONM) shares rose 28.03% to $0.72. The stock is trading 43.77% lower than a month ago.
SXTC25.58%CHINA SXT PHARMACEUTICALS IN's (NASDAQ:SXTC) stock price is advancing with 25.58% to a price of $1.08. In the last month the share price dropped with 39.01%.
ILAG24.51%INTELLIGENT LIVING APPLICATI (NASDAQ:ILAG) rose 24.51% to $2.54 during Tuesday's pre-market session. Also in the previous session NASDAQ:ILAG had a very good day: shares closed with a 11.48% gain.
NMTR21.98%9 METERS BIOPHARMA INC's (NASDAQ:NMTR) shares rose 21.98% to $0.25 during Tuesday's pre-market session. The stock is trading 31.02% lower than a month ago.
AVCTW20.0%PENSARE ACQUISITION CORP-CW's (NASDAQ:AVCTW) shares rose 20.0% to $0.08. In the last month the share price increased with 56.25%.
BTB19.2%BIT BROTHER LTD's (NASDAQ:BTB) stock price is advancing with 19.2% to a price of $0.15. Prices are quite volatile here as yesterday NASDAQ:BTB closed with a -12.46% loss.
AYLA19.05%AYALA PHARMACEUTICALS INC's (NASDAQ:AYLA) stock price is advancing with 19.05% to a price of $1.25. The stock is trading 36.75% lower than a month ago.
MF17.98%MISSFRESH LTD-ADR's (NASDAQ:MF) stock price is advancing with 17.98% to a price of $0.1. Shareholders saw the stock price going 34.32% lower in the past month.
STIM15.2%NEURONETICS INC's (NASDAQ:STIM) stock price increased by 15.2% to $2.72. Shareholders saw the stock price going 43.13% lower in the past month.

Our premarket gainers screener will show you the full list.

Pre-market losers

TickerChangeComment
ARDS-34.14%ARIDIS PHARMACEUTICALS INC's (NASDAQ:ARDS) stock price decreased by 34.14% to $0.56. Yesterday's drop of -29.73% continued in today's pre-market session with another decline of 34.14%
RNA-24.32%AVIDITY BIOSCIENCES INC's (NASDAQ:RNA) stock price decreased by 24.32% to $14.19. Shareholders saw the stock price going 21.28% higher in the past 3 months.
AMST-13.41%AMESITE INC's (NASDAQ:AMST) stock price is declining with 13.41% to a price of $0.25. Shareholders saw the stock price going 61.84% lower in the past month.
FNHC-9.13%FEDNAT HOLDING CO's (NASDAQ:FNHC) stock price is declining with 9.13% to a price of $0.2. NASDAQ:FNHC already had a hard day yesterday: closing -15.86% lower during the regular session.
LAUR-8.91%LAUREATE EDUCATION INC's (NASDAQ:LAUR) shares fell 8.91% to $10.02. Shareholders saw the stock price going 38.85% lower is the past year.
PFLT-7.79%PENNANTPARK FLOATING RATE CA's (NYSE:PFLT) stock price decreased by 7.79% to $9.0. The stock is trading 20.39% lower than a month ago.
AKTX-7.1%AKARI THERAPEUTICS PLC-ADR's (NASDAQ:AKTX) stock price decreased by 7.1% to $0.51. The stock is trading 53.87% lower than a month ago.
NVIV-6.99%INVIVO THERAPEUTICS HOLDINGS's (NASDAQ:NVIV) stock price decreased by 6.99% to $3.86. Shareholders saw the stock price going 41.34% lower in the past month.
MTP-6.92%MIDATECH PHARMA PLC-ADR's (NASDAQ:MTP) stock price is declining with 6.92% to a price of $2.42. After yesterdays gain of 373.0%, it goes down with 6.92% in today's pre-market session.
KXIN-6.73%KAIXIN AUTO HOLDINGS's (NASDAQ:KXIN) stock price is declining with 6.73% to a price of $0.91. In the last month the share price increased with 23.66%.

Our premarket losers screener will show you the full list.

Back

STIM Links

STIM News

News Image11 days ago - NeuroneticsNeuronetics to Present at the Piper Sandler 34th Annual Healthcare Conference

MALVERN, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing,...

News Image19 days ago - NeuroneticsNeuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations

Enhancements further establish the Company’s leadership position as the top transcranial magnetic stimulation therapy...

News Image19 days ago - NeuroneticsNeuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations

Enhancements further establish the Company’s leadership position as the top transcranial magnetic stimulation therapy

News Image23 days ago - NeuroneticsNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

News Image25 days ago - NeuroneticsNeuronetics Reports Third Quarter 2022 Financial and Operating Results

MALVERN, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision...

News Imagea month ago - NeuroneticsNeuronetics Announced as Winner by 2022 Merit Awards for Technology

NeuroStar technology is acknowledged for its innovation and accessibility as a non-drug treatment for mental health

News Imagea month ago - NeuroneticsNeuronetics Announced as Winner by 2022 Merit Awards for Technology

NeuroStar technology is acknowledged for its innovation and accessibility as a non-drug treatment for mental health...

News Imagea month ago - NeuroneticsNeuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to NeuroStar TMS Therapy for Mental Health

Published and Proposed Medicare Coverage through CGS and NGS MACs Will Reduce Number of Medication Trials, Leading to Increased Eligibility for TMS

News Imagea month ago - NeuroneticsNeuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to NeuroStar TMS Therapy for Mental Health

Published and Proposed Medicare Coverage through CGS and NGS MACs Will Reduce Number of Medication Trials, Leading to Increased Eligibility for TMS...

News Imagea month ago - NeuroneticsNeuronetics to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

News Image2 months ago - NeuroneticsNeuronetics Launches Innovations To NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform

Upgrades will enhance and automate the patient candidate experience for all NeuroStar providers, leading to faster patient identification of those in need...

Follow us for more